?1
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-16 03:36:00 UTC
Verified By
Rollup News
Indonesia faces a severe tuberculosis (TBC) crisis with 889,000 cases and 125,000 deaths annually, ranking second globally. The country is now a testing ground for the M72/AS01E vaccine, supported by the Gates Foundation, showing 50% efficacy in trials. This vaccine targets adults, unlike the BCG vaccine for children, aiming to reduce TBC cases in Indonesia.
High TBC cases and deaths in Indonesia
Indonesia as a testing ground for M72/AS01E vaccine
Support from the Gates Foundation
Vaccine efficacy of 50%
Targeting adults with the new vaccine
High number of TBC cases
High mortality rate due to TBC
Need for effective TBC prevention methods for adults